Beam Therapeutics sued YolTech's Yuxuan Wu & Zi Jun Wang and Serapha Bio for allegedly stealing trade secrets related to ...
Former House majority leader Eric Cantor has been chosen as PhRMA’s next CEO, according to two sources familiar ...
UniQure's shares were rocked Tuesday morning after the company revealed its experimental Huntington’s disease gene therapy ...
Breye Therapeutics raised €67.5M Series A; Aptadir raised €40M seed; Ascletis' ASC50 shows psoriasis results; Invivyd touts ...
Oura delays IPO citing market uncertainty despite $1.2B revenue and strong demand. Anthropic, OpenAI, Holtec, and Bamboo ...
ARCH and Population Health launch Somnivera with a $10.5M-upfront deal for an ex-China sleep drug from Jiangsu Nhwa.
The cash should give the Stockholm-based biotech a runway “well into 2029,” CEO Patrik Strömberg told Endpoints News in ...
Ex-Genentech AI leaders including NYU's Kyunghyun Cho launch health startup Ortet with a $500M commitment from Matt Holt's ...
Bio raises $48M Series A led by UPMC Enterprises & Ziff Capital to target Th17 cells via CD161+ antibody & CAD mRNA platforms ...
Fresenius Kabi will sell biosimilars for Humira, Stelara & Actemra directly to employers via Eversana's Waltz Health, with ...
At the end of 2027, BioNTech will exit factories in Idar-Oberstein and Marburg and a site in Tübingen that was ...
Massachusetts is often considered the epicenter of the biotech industry because of its nucleus of world-class research institutions churning out new scientists and new startups.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results